Pesquisar
Virax Biolabs Group Ltd
VRAXAdicionar à lista de desejos
3.130USD
+0.390+14.23%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
13.59MValor de mercado
PerdaP/L TTM
Mais detalhes de Virax Biolabs Group Ltd Empresa
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Informações de Virax Biolabs Group Ltd
Código da empresaVRAX
Nome da EmpresaVirax Biolabs Group Ltd
Data de listagemJul 14, 2022
CEOFoster (James)
Número de funcionários19
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 14
EndereçoBiocity Glasgow
CidadeLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalML1 5UH
Telefone4402077887414
Sitehttps://www.viraxbiolabs.com
Código da empresaVRAX
Data de listagemJul 14, 2022
CEOFoster (James)
Executivos da empresa Virax Biolabs Group Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
11.52K
--
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
613.00
--
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
11.52K
--
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
613.00
--
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Virax Biolabs Group Ltd?
Os cinco principais acionistas de Virax Biolabs Group Ltd são: Mr. James Foster
Quantas instituições possuem ações da Virax Biolabs Group Ltd (VRAX)?
Em 2026Q1, 22 instituições possuíam ações da Virax Biolabs Group Ltd, com valor de mercado aproximado de 851.39K, representando 4.27% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 268600.00.